Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene

EU orphan designation number: EU/3/17/1935   
Active ingredient: 1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene
Indication: Treatment of non-traumatic subarachnoid haemorrhage
Sponsor: Edvince AB
Medicon Village, Scheelevägen 2, 223 81 Lund, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
10/11/2017 Orphan designation EMA/OD/120/17 (2017)7557 of 8/11/2017